What's the usual cosentyx dose for psoriasis?

Choosing the Right Dose: Cosentyx for Psoriasis

[1] According to the European Medicines Agency (EMA) [1], Cosentyx (secukinumab) is a biologic medication used to treat moderate to severe plaque psoriasis in adults.

Dosing Recommendations

The recommended dose of Cosentyx for treating psoriasis is 300 mg administered subcutaneously at weeks 0, 1, 2, 3, and 4, followed by 300 mg every 4 weeks.

Loading Dose

A loading dose is a higher dose given initially to achieve a faster therapeutic effect. In the case of Cosentyx, the loading dose is recommended for patients with moderate to severe plaque psoriasis.

Maintenance Dose

After the loading dose, the maintenance dose is 300 mg every 4 weeks. This dose helps to maintain control of the psoriasis symptoms and prevent flare-ups.

Dose Adjustments

[2] Patients with renal impairment or those taking other medications that may interact with Cosentyx should be closely monitored by their healthcare provider. Adjustments to the dose may be necessary in these cases.

Concomitant Therapy

Cosentyx can be used with or without concomitant topical therapy, phototherapy, or systemic treatment.

Real-World Experience

DrugsData [3] reports that, in clinical trials, Cosentyx showed significant improvements in psoriasis symptoms, including reduction in plaque thickness and severity.

Patent and Exclusivity

[4] The Cosentyx patent is owned by Novartis Pharmaceuticals Corporation, with exclusivity set to expire in 2032. This may impact access to the medication as generic versions become available.

References:
[1] European Medicines Agency (EMA). Secukinumab. 2022.
[2] Drugs.com. Secukinumab (Cosentyx) dosing. 2022.
[3] DrugsData. Cosentyx: efficacy, safety, and dosing in psoriasis. 2022.
[4] DrugPatentWatch.com. Secukinumab. 2022.